Immunotherapy Promising for Slowing Progression of ALS – Monthly Prescribing Reference
|
Immunotherapy Promising for Slowing Progression of ALS
Monthly Prescribing Reference HealthDay News — A new immunotherapy appears to be well tolerated and possibly of benefit in patients with amyotrophic lateral sclerosis (ALS), according to a phase 1, first-in-human study published online May 18 in Neurology: Neuroimmunology … |
